PATENT CLAIM ANALYSIS

Application Number: 16017489
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["530", "387100"]

Abstract:
Provided herein are antibodies, or antigen-binding portions thereof, that bind to T-cell immunoglobulin and mucin-domain containing-3 (TIM3) protein. Also provided are uses of these antibodies, or antigen-binding portions thereof, in therapeutic applications, such as treatment of cancer. Further provided are cells that produce the antibodies, or antigen-binding portions thereof, polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof, and vectors comprising the polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof.

Claim (Index 49):
The antibody, or antigen binding portion thereof, of  claim 47 , wherein the antibody comprises an effectorless IgG1 Fc.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 94.0
- Lexical Diversity: 2.08511
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15649380', '15520638', '13478786', '14732082', '15474731']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7594763701672467
- 35 USC 102 Novelty (BERT): 0.6984381901163187
- Combined Prediction Score: 0.7533725521621538
- Mean Citation Score: 596.4244480000001
- Max Citation Score: 837.39594
- Similarity Product: 694.6788954853462

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test